Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Platelet-rich plasma may help stabilize vitiligo by supporting melanocyte survival, modulating the immune response, and enhancing repigmentation when used alongside phototherapy or topical treatments. Early studies report faster and more extensive pigment return compared to standard therapies, but they are limited by small sample sizes, varied preparation methods, and unknown long-term stability.
See below for a full discussion of candidate selection, treatment protocols, benefits, risks, and next steps to consider with your dermatologist.
Vitiligo is a chronic skin condition characterized by the loss of pigment in patches, affecting roughly 1% of the global population. People with vitiligo often seek treatments to slow progression and restore color. One emerging approach is platelet-rich plasma (PRP). This article explores current research on PRP for vitiligo, its potential benefits, limitations, and what to discuss with your healthcare provider.
Vitiligo occurs when melanocytes (the cells that produce pigment) are destroyed or stop functioning. Key points about vitiligo:
Despite these options, many patients seek adjunctive therapies to amplify repigmentation and improve stability. This is where "PRP for vitiligo" comes into focus.
Platelet-Rich Plasma (PRP) is a concentration of a patient's own platelets suspended in a small volume of plasma. It's prepared by drawing blood, spinning it in a centrifuge, and collecting the platelet-rich layer. Key components:
PRP has been studied in orthopedics, dermatology (hair restoration, acne scars) and increasingly in pigment disorders like vitiligo.
Researchers propose several mechanisms by which PRP might stabilize vitiligo and promote repigmentation:
Support for Melanocyte Survival
Modulation of Immune Response
Stimulation of Stem Cells
Improved Skin Microenvironment
While research is still early, several small studies and case series shed light on PRP's potential:
Pilot Studies
Randomized Trials
Case Series
Limitations of current research:
Before considering PRP, weigh potential benefits against practical considerations:
Benefits
Considerations
PRP for vitiligo is still experimental, but you might discuss it with a dermatologist if you:
Your doctor will assess:
Most clinics recommend 4–6 sessions spaced 2–4 weeks apart. Mild swelling, redness, or bruising at injection sites is common but usually resolves in 1–3 days.
PRP is generally well tolerated because it's autologous, but risks include:
Always choose a board-certified dermatologist or trained clinician with experience in PRP.
Evidence suggests the best outcomes come from multimodal therapy. Common combinations:
Your dermatologist will tailor a plan based on your skin type, vitiligo activity, and treatment goals.
If you're exploring PRP for vitiligo:
Before your next appointment, you can use a free AI-powered symptom checker for Vitiligo Vulgaris to better understand your symptoms and prepare more informed questions for your doctor.
Research into "PRP for vitiligo" is promising but still evolving. PRP may offer an additional tool to stabilize and repigment vitiligo, especially when combined with established therapies. However, results vary, and long-term data are limited.
Before making any decisions:
Always speak to a doctor about anything life-threatening, persistent, or seriously concerning. Your healthcare provider can guide you toward the safest, most effective plan for your vitiligo journey.
(References)
* Albalawi, R., Albalawi, A., Aldawoud, H., Abalan, Z., Abualsaud, M., Mufareh, A., Alharbi, A., & Albakri, M. (2024). Platelet-rich plasma in vitiligo: A systematic review and meta-analysis. *Journal of Cosmetic Dermatology*, *23*(2), 481-490. 38202517
* Khan, S., Hussain, B., Khan, H., Ali, T., Qamar, T., & Khan, I. (2023). Platelet-rich plasma: A promising therapy for vitiligo. *Journal of Cosmetic Dermatology*, *22*(10), 2686-2696. 37604313
* Mokthar, S. N., Abdo, R. M., & Gad, A. H. (2023). Efficacy of platelet-rich plasma versus autologous non-cultured epidermal cell suspension in combination with Narrow Band-Ultraviolet B in treatment of stable vitiligo: A randomized controlled trial. *Journal of Cosmetic Dermatology*, *22*(12), 3326-3333. 37775924
* Alotaibi, N. M., Alotaibi, A. M., Almutairi, K. M., Aljindan, M. A., Alkhamis, A. S., Alotaibi, N. N., & Alrasheedi, M. M. (2023). Platelet-Rich Plasma in Vitiligo: A Systematic Review. *Skin Appendage Disorders*, *9*(5), 416-424. 37575218
* Abbas, A., Nofal, E., Hussein, R., Al-Sayyad, A., Salem, N., Shoukry, D., Al-Gamal, A., & Mohamed, A. (2024). Is platelet-rich plasma a promising agent for vitiligo? *Journal of Cosmetic Dermatology*, *23*(1), 163-171. 38075775
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.